Search Results - "OKAZAKI, Taku"

Refine Results
  1. 1

    PD-1 and PD-1 ligands: from discovery to clinical application by Okazaki, Taku, Honjo, Tasuku

    Published in International immunology (01-07-2007)
    “…Programmed cell death-1 (PD-1, Pdcd1), an immunoreceptor belonging to the CD28/CTLA-4 family negatively regulates antigen receptor signaling by recruiting…”
    Get full text
    Journal Article
  2. 2

    Restriction of PD-1 function by cis -PD-L1/CD80 interactions is required for optimal T cell responses by Sugiura, Daisuke, Maruhashi, Takumi, Okazaki, Il-Mi, Shimizu, Kenji, Maeda, Takeo K, Takemoto, Tatsuya, Okazaki, Taku

    “…Targeted blockade of PD-1 with immune checkpoint inhibitors can activate T cells to destroy tumors. PD-1 is believed to function mainly at the effector, but…”
    Get full text
    Journal Article
  3. 3

    LAG-3: from molecular functions to clinical applications by Maruhashi, Takumi, Sugiura, Daisuke, Okazaki, Il-Mi, Okazaki, Taku

    Published in Journal for immunotherapy of cancer (01-09-2020)
    “…To prevent the destruction of tissues owing to excessive and/or inappropriate immune responses, immune cells are under strict check by various regulatory…”
    Get full text
    Journal Article
  4. 4

    The PD-1–PD-L pathway in immunological tolerance by Okazaki, Taku, Honjo, Tasuku

    Published in Trends in Immunology (01-04-2006)
    “…Since the first observation of spontaneous autoimmune diseases in programmed cell death 1 (PD-1) knockout mice, PD-1 has been postulated to have essential…”
    Get full text
    Journal Article
  5. 5

    PD-1 deficiency results in the development of fatal myocarditis in MRL mice by Wang, Jian, Okazaki, Il-mi, Yoshida, Taku, Chikuma, Shunsuke, Kato, Yu, Nakaki, Fumio, Hiai, Hiroshi, Honjo, Tasuku, Okazaki, Taku

    Published in International immunology (01-06-2010)
    “…The deficiency of programmed cell death 1 (PD-1, Pdcd1), a negative immuno-receptor belonging to the CD28/cytotoxic T lymphocyte antigen 4 (CTLA-4) family, can…”
    Get full text
    Journal Article
  6. 6

    PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation by Mizuno, Reina, Sugiura, Daisuke, Shimizu, Kenji, Maruhashi, Takumi, Watada, Mizuki, Okazaki, Il-Mi, Okazaki, Taku

    Published in Frontiers in immunology (29-03-2019)
    “…Cancer-immunotherapy targeting programmed cell death 1 (PD-1) activates tumor-specific T cells and provides clinical benefits in various cancers. However, the…”
    Get full text
    Journal Article
  7. 7

    Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma by Hino, Ryosuke, Kabashima, Kenji, Kato, Yu, Yagi, Hiroaki, Nakamura, Motonobu, Honjo, Tasuku, Okazaki, Taku, Tokura, Yoshiki

    Published in Cancer (01-04-2010)
    “…BACKGROUND: Melanoma tends to be refractory to various immunotherapies because of tumor‐induced immunosuppression. To investigate the mechanism underlining the…”
    Get full text
    Journal Article
  8. 8

    PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity by Sugiura, Daisuke, Okazaki, Il-mi, Maeda, Takeo K., Maruhashi, Takumi, Shimizu, Kenji, Arakaki, Rieko, Takemoto, Tatsuya, Ishimaru, Naozumi, Okazaki, Taku

    Published in Nature immunology (01-03-2022)
    “…Targeted blockade of the checkpoint molecule programmed cell death 1 (PD-1) can activate tumor-specific T cells to destroy tumors, whereas targeted…”
    Get full text
    Journal Article
  9. 9

    A battle between two biological singularities: Immune response vs. cancer by Katakai, Tomoya, Okazaki, Taku

    Published in Biophysics and Physicobiology (01-01-2024)
    “…In a post-growth multicellular organism, the phenomenon in which a small number of rare cells can be the starting point for inducing a dramatic change in the…”
    Get full text
    Journal Article
  10. 10

    T-cell-intrinsic and -extrinsic regulation of PD-1 function by Sugiura, Daisuke, Shimizu, Kenji, Maruhashi, Takumi, Okazaki, Il-mi, Okazaki, Taku

    Published in International immunology (01-12-2021)
    “…Abstract Cancer immunotherapies that target PD-1 (programmed cell death 1) aim to destroy tumors by activating tumor-specific T cells that are otherwise…”
    Get full text
    Journal Article
  11. 11
  12. 12

    PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice by Okazaki, Taku, Okazaki, Il-mi, Wang, Jian, Sugiura, Daisuke, Nakaki, Fumio, Yoshida, Taku, Kato, Yu, Fagarasan, Sidonia, Muramatsu, Masamichi, Eto, Tomoo, Hioki, Kyoji, Honjo, Tasuku

    Published in The Journal of experimental medicine (14-02-2011)
    “…Stimulatory and inhibitory co-receptors play fundamental roles in the regulation of the immune system. We describe a new mouse model of spontaneous autoimmune…”
    Get full text
    Journal Article
  13. 13

    Involvement of PD-L1 on Tumor Cells in the Escape from Host Immune System and Tumor Immunotherapy by PD-L1 Blockade by Iwai, Yoshiko, Ishida, Masayoshi, Tanaka, Yoshimasa, Okazaki, Taku, Honjo, Tasuku, Minato, Nagahiro

    “…PD-1 is a receptor of the Ig superfamily that negatively regulates T cell antigen receptor signaling by interacting with the specific ligands (PD-L) and is…”
    Get full text
    Journal Article
  14. 14

    PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors by Lin, David Yin-wei, Tanaka, Yoshimasa, Iwasaki, Masashi, Gittis, Apostolos G, Su, Hua-Poo, Mikami, Bunzo, Okazaki, Taku, Honjo, Tasuku, Minato, Nagahiro, Garboczi, David N

    “…Signaling through the programmed death 1 (PD-1) inhibitory receptor upon binding its ligand, PD-L1, suppresses immune responses against autoantigens and tumors…”
    Get full text
    Journal Article
  15. 15

    Establishment of NOD-Pdcd1-/-Mice as an Efficient Animal Model of Type I Diabetes by Wang, Jian, Yoshida, Taku, Nakaki, Fumio, Hiai, Hiroshi, Okazaki, Taku, Honjo, Tasuku

    “…Mice deficient in programmed cell death 1 (PD-1, Pdcd1), an immunoinhibitory receptor belonging to the CD28/cytotoxic T lymphocyte-associated antigen-4 family,…”
    Get full text
    Journal Article
  16. 16

    Intestinal CX3C chemokine receptor 1high (CX3CR1high) myeloid cells prevent T-cell-dependent colitis by Kayama, Hisako, Ueda, Yoshiyasu, Sawa, Yukihisa, Jeon, Seong Gyu, Ma, Ji Su, Okumura, Ryu, Kubo, Atsuko, Ishii, Masaru, Okazaki, Taku, Murakami, Masaaki, Yamamoto, Masahiro, Yagita, Hideo, Takeda, Kiyoshi

    “…Adequate activation of CD4+ T lymphocytes is essential for host defense against invading pathogens; however, exaggerated activity of effector CD4+ T cells…”
    Get full text
    Journal Article
  17. 17

    PD-1 Immunoreceptor Inhibits B Cell Receptor-Mediated Signaling by Recruiting Src Homology 2-Domain-Containing Tyrosine Phosphatase 2 to Phosphotyrosine by Okazaki, Taku, Maeda, Akito, Nishimura, Hiroyuki, Kurosaki, Tomohiro, Honjo, Tasuku

    “…PD-1 is an immunoreceptor that belongs to the immunoglobulin (Ig) superfamily and contains two tyrosine residues in the cytoplasmic region. Studies on…”
    Get full text
    Journal Article
  18. 18

    Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice by Honjo, Tasuku, Okazaki, Taku, Tanaka, Yoshimasa, Nishio, Ryosuke, Mitsuiye, Tamotsu, Mizoguchi, Akira, Wang, Jian, Ishida, Masayoshi, Hiai, Hiroshi, Matsumori, Akira, Minato, Nagahiro

    Published in Nature medicine (01-12-2003)
    “…We recently reported that mice deficient in the programmed cell death-1 (PD-1) immunoinhibitory coreceptor develop autoimmune dilated cardiomyopathy (DCM),…”
    Get full text
    Journal Article
  19. 19

    PD-1 inhibits antiviral immunity at the effector phase in the liver by Iwai, Yoshiko, Terawaki, Seigo, Ikegawa, Masaya, Okazaki, Taku, Honjo, Tasuku

    Published in The Journal of experimental medicine (07-07-2003)
    “…Unlike naive T cells, effector T cells can be activated by either T cell receptor signal or costimulatory signal alone and therefore the absence of…”
    Get full text
    Journal Article
  20. 20

    New regulatory co-receptors: inducible co-stimulator and PD-1 by Okazaki, Taku, Iwai, Yoshiko, Honjo, Tasuku

    Published in Current Opinion in Immunology (01-12-2002)
    “…Autoreactive lymphocytes are suppressed in healthy individuals by so-called peripheral tolerance. Accumulating evidence indicates that co-receptor signaling…”
    Get full text
    Book Review Journal Article